Erratum: PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: Biodistribution in humans and first evaluation of tumour lesions (European Journal of Nuclear Medicine and Molecular Imaging DOI: 10.1007/s00259-012-2298-2);Pet imaging with a [68ga]gallium-labelled psma ligand for the diagnosis of prostate cancer: Biodistribution in humans and first evaluation of tumour lesions

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 40, Issue 4, 2013, Pages 486-495

  Afshar Oromieh, A ^a   Malcher, A ^a   Eder, M ^b   Eisenhut, M ^b   Linhart, H G ^b   Hadaschik, B A ^a   Holland Letz, T ^b   Giesel, F L ^a   Kratochwil, C ^a   Haufe, S ^a   Haberkorn, U ^a,b   Zechmann, C M ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

PET CT; Positron emission tomography; Prostate cancer; Prostate specific membrane antigen; PSMA

Indexed keywords

DIAGNOSTIC AGENT; DRUG DERIVATIVE; EDETIC ACID; GALLIUM; GLU NH CO NH LYS (AHX) ((68)GA(HBED CC)); GLU-NH-CO-NH-LYS-(AHX)-((68)GA(HBED-CC)); GLUTAMATE CARBOXYPEPTIDASE II; GLUTAMATE CARBOXYPEPTIDASE II, HUMAN; LIGAND; MEMBRANE ANTIGEN; OLIGOPEPTIDE; RADIOPHARMACEUTICAL AGENT;

AGED; ARTICLE; CARCINOMA; COMPUTER ASSISTED EMISSION TOMOGRAPHY; HUMAN; MALE; MIDDLE AGED; PROSTATE TUMOR; SCINTISCANNING; TISSUE DISTRIBUTION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTIGENS, SURFACE; CARCINOMA; EDETIC ACID; GALLIUM RADIOISOTOPES; GLUTAMATE CARBOXYPEPTIDASE II; HUMANS; LIGANDS; MALE; MIDDLE AGED; OLIGOPEPTIDES; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PROSTATIC NEOPLASMS; RADIOPHARMACEUTICALS; TISSUE DISTRIBUTION;

EID: 85028116944     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-013-2378-y     Document Type: Erratum

References (16)

1. Sweat SD, Pacelli A, Murphy GP, Bostwick DG. Prostate-specific membrane antigen expression is greatest in prostate adenocarcinoma and lymph node metastases. Urology 1998;52(4):637–40.
2. Mannweiler S, Amersdorfer P, Trajanoski S, Terrett JA, King D, Mehes G. Heterogeneity of prostate-specific membrane antigen (PSMA) expression in prostate carcinoma with distant metastasis. Pathol Oncol Res 2009;15(2):167–72.
3. Ghosh A, Heston WD. Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer. J Cell Biochem 2004;91:528–39.
4. Bander NH. Technology insight: monoclonal antibody imaging of prostate cancer. Nat Clin Pract Urol 2006;3(4):216–25.
5. Liu H, Moy P, Kim S, Xia Y, Rajasekaran A, Navarro V., et al. Monoclonal antibodies to the extracellular domain of prostate-specific membrane antigen also react with tumor vascular endo-thelium. Cancer Res 1997;57(17):3629–34.
6. Hillier SM, Maresca KP, Femia FJ, Marquis JC, Foss CA, Nguyen N., et al. Preclinical evaluation of novel glutamate-urea-lysine analogues that target prostate-specific membrane antigen as molecular imaging pharmaceuticals for prostate cancer. Cancer Res 2009;69(17):6932–40.
7. Eder M, Schäfer M, Bauder-Wüst U, Hull WE, Wangler C, Mier W., et al. (68)Ga-complex lipophilicity and the targeting property of a urea-based PSMA inhibitor for PET imaging. Bioconjug Chem 2012;23:688–97.
8. Banerjee SR, Foss CA, Castanares M, Mease RC, Byun Y, Fox JJ., et al. Synthesis and evaluation of technetium-99m-and rhenium-labeled inhibitors of the prostate-specific membrane antigen (PSMA). J Med Chem 2008;51(15):4504–17.
9. Afshar-Oromieh A, Haberkorn U, Eder M, Eisenhut M, Zechmann C. [(68)Ga]Gallium-labelled PSMA ligand as superior PET tracer for the diagnosis of prostate cancer: comparison with (18)F-FECH. Eur J Nucl Med Mol Imaging 2012;39(6):1085–6.
10. Schuhmacher J, Maier-Borst W. A new 68Ge/68Ga radioisotope generator system for production of 68Ga in dilute HCl. Int J Appl Radiat Isot 1981;32:31–6.
11. Schäfer M, Bauder-Wüst U, Leotta K, Zoller F, Mier W, Haberkorn U., et al. A dimerized urea-based inhibitor of the prostate-specific membrane antigen for 68Ga-PET imaging of prostate cancer. EJNMMI Res 2012;2(1):23.
12. Human protein atlas. FOLH1. http://www.proteinatlas.org/ENSG00000086205/normal.
13. Silver DA, Pellicer I, Fair WR, Heston WD, Cordon-Cardo C. Prostate-specific membrane antigen expression in normal and malignant human tissues. Clin Cancer Res 1997;3(1):81–5.
14. Gordon IO, Tretiakova MS, Noffsinger AE, Hart J, Reuter VE, Al-Ahmadie HA. Prostate-specific membrane antigen expression in regeneration and repair. Mod Pathol 2008;21(12):1421–7.
15. Maraj BH, Aldersley MA, Markham AF. Prostate-specific membrane antigen expression in the duodenum: implications in coeliac disease and immunotherapy for prostate cancer. Lancet 1998;351 (9115):1559–60.
16. Bostwick DG, Pacelli A, Blute M, Roche P, Murphy GP. Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 184 cases. Cancer 1998;82(11):2256–61.